VALID TRIAL
Both CHIA and your personal trial have the following criteria:
╒════════════════════════════════════════════════════╤════════════════════════════════════════════════════╤═════════╕
│ Personal Criteria                                  │ CHIA Criteria                                      │   Score │
╞════════════════════════════════════════════════════╪════════════════════════════════════════════════════╪═════════╡
│ Is not of reproductive potential, or is of         │ Is not of reproductive potential, or is of         │     100 │
│ reproductive potential and agrees to avoid         │ reproductive potential and agrees to avoid         │         │
│ becoming pregnant or impregnating a partner while  │ becoming pregnant or impregnating a partner while  │         │
│ receiving trial medication or within 6 months      │ receiving trial medication or within 6 months      │         │
│ after the last dose of trial medication            │ after the last dose of trial medication            │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Has elevated CRP at Screening or evidence of       │ Has elevated CRP at Screening or evidence of       │     100 │
│ active inflammation in the sacroiliac joints on    │ active inflammation in the sacroiliac joints on    │         │
│ MRI                                                │ MRI                                                │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Has an acceptable history of NSAID use             │ Has an acceptable history of NSAID use             │     100 │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Has no history of untreated latent or active       │ Has no history of untreated latent or active       │     100 │
│ tuberculosis (TB) prior to Screening               │ tuberculosis (TB) prior to Screening               │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Has had no recent close contact with a person with │ Has had no recent close contact with a person with │     100 │
│ active TB or, if there has been such contact, will │ active TB or, if there has been such contact, will │         │
│ undergo additional evaluations and receive         │ undergo additional evaluations and receive         │         │
│ appropriate treatment for latent TB                │ appropriate treatment for latent TB                │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Is a nursing or pregnant female, or intends to     │ Is a nursing or pregnant female, or intends to     │     100 │
│ become pregnant within 6 months after receiving    │ become pregnant within 6 months after receiving    │         │
│ trial medication                                   │ trial medication                                   │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Intends to donate eggs (female participants) or    │ Intends to donate eggs (female participants) or    │     100 │
│ sperm (male participants) while receiving trial    │ sperm (male participants) while receiving trial    │         │
│ medication or within 6 months after trial          │ medication or within 6 months after trial          │         │
│ medication                                         │ medication                                         │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Has any clinically significant condition or        │ Has any clinically significant condition or        │     100 │
│ situation that would interfere with the trial      │ situation that would interfere with the trial      │         │
│ evaluations or participation in the trial          │ evaluations or participation in the trial          │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Has ever received any cytotoxic drugs, including   │ Has ever received any cytotoxic drugs, including   │     100 │
│ chlorambucil, cyclophosphamide, nitrogen mustard,  │ chlorambucil, cyclophosphamide, nitrogen mustard,  │         │
│ or other alkylating agents                         │ or other alkylating agents                         │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ • Disease-modifying anti-rheumatic drugs (30 days  │ • Disease-modifying anti-rheumatic drugs (30 days  │     100 │
│ off drug)                                          │ off drug)                                          │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ • Live vaccinations (3 months off drug)            │ • Live vaccinations (3 months off drug)            │     100 │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ • Investigational medications (30 days or 5 half-  │ • Investigational medications (30 days or 5 half-  │     100 │
│ lives off drug, whichever is longer)               │ lives off drug, whichever is longer)               │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ • Bacille Calmette-Guerin (BCG) vaccination (12    │ • Bacille Calmette-Guerin (BCG) vaccination (12    │     100 │
│ months off drug)                                   │ months off drug)                                   │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Has any systemic inflammatory condition, including │ Has any systemic inflammatory condition, including │     100 │
│ psoriatic arthritis, active Lyme disease, systemic │ psoriatic arthritis, active Lyme disease, systemic │         │
│ lupus erythematosus, infectious arthritis,         │ lupus erythematosus, infectious arthritis,         │         │
│ vasculitis, parvovirus infection, rheumatoid       │ vasculitis, parvovirus infection, rheumatoid       │         │
│ arthritis, active uveitis, or active IBD           │ arthritis, active uveitis, or active IBD           │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Has a history of latent or active granulomatous    │ Has a history of latent or active granulomatous    │     100 │
│ infection prior to Screening                       │ infection prior to Screening                       │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Had a nontuberculous mycobacterial infection or    │ Had a nontuberculous mycobacterial infection or    │     100 │
│ opportunistic infection within 6 months prior to   │ opportunistic infection within 6 months prior to   │         │
│ Screening                                          │ Screening                                          │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Has a history of an infected joint prosthesis, or  │ Has a history of an infected joint prosthesis, or  │     100 │
│ has received antibiotics for a suspected infection │ has received antibiotics for a suspected infection │         │
│ of a joint prosthesis, if that prosthesis has not  │ of a joint prosthesis, if that prosthesis has not  │         │
│ been removed or replaced                           │ been removed or replaced                           │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Had a serious infection, has been hospitalized for │ Had a serious infection, has been hospitalized for │     100 │
│ an infection, or has been treated with IV          │ an infection, or has been treated with IV          │         │
│ antibiotics for an infection within 2 months prior │ antibiotics for an infection within 2 months prior │         │
│ to Baseline                                        │ to Baseline                                        │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Had a history of, or ongoing, chronic or recurrent │ Had a history of, or ongoing, chronic or recurrent │     100 │
│ infectious disease                                 │ infectious disease                                 │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Is known to be infected with human                 │ Is known to be infected with human                 │     100 │
│ immunodeficiency virus (HIV) or seropositive for   │ immunodeficiency virus (HIV) or seropositive for   │         │
│ hepatitis C virus (HCV)                            │ hepatitis C virus (HCV)                            │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Has had a chest x-ray within 2 months prior to     │ Has had a chest x-ray within 2 months prior to     │     100 │
│ Screening that shows an abnormality suggestive of  │ Screening that shows an abnormality suggestive of  │         │
│ a current active infection or malignancy           │ a current active infection or malignancy           │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Has a history of lymphoproliferative disease       │ Has a history of lymphoproliferative disease       │     100 │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Has had a malignancy within 5 years before         │ Has had a malignancy within 5 years before         │     100 │
│ screening (exceptions are squamous and basal cell  │ screening (exceptions are squamous and basal cell  │         │
│ carcinomas of the skin and carcinoma in situ of    │ carcinomas of the skin and carcinoma in situ of    │         │
│ cervix that has been surgically cured)             │ cervix that has been surgically cured)             │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Has a history of known demyelinating diseases such │ Has a history of known demyelinating diseases such │     100 │
│ as multiple sclerosis or optic neuritis            │ as multiple sclerosis or optic neuritis            │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Has a history of or concurrent congestive heart    │ Has a history of or concurrent congestive heart    │     100 │
│ failure of any grade                               │ failure of any grade                               │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Has a transplanted organ (with the exception of a  │ Has a transplanted organ (with the exception of a  │     100 │
│ corneal transplant performed \>= 3 months prior to │ corneal transplant performed >= 3 months prior to  │         │
│ baseline)                                          │ baseline)                                          │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Has current signs or symptoms of significant       │ Has current signs or symptoms of significant       │     100 │
│ medical illness which could interfere with the     │ medical illness which could interfere with the     │         │
│ trial, or require treatment that might interfere   │ trial, or require treatment that might interfere   │         │
│ with the trial                                     │ with the trial                                     │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Is a user of recreational or illicit drugs or has  │ Is a user of recreational or illicit drugs or has  │     100 │
│ or had a substance abuse (drug or alcohol) problem │ or had a substance abuse (drug or alcohol) problem │         │
│ within the previous 2 years                        │ within the previous 2 years                        │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Has bilateral sacroiliitis Grade 2 or unilateral   │ Has bilateral sacroiliitis Grade 2 or unilateral   │      87 │
│ sacroiliitis Grade 3 or Grade 4 on conventional    │ sacroiliitis Grade 3 or Grade 4                    │         │
│ x-rays                                             │                                                    │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Human leukocyte antigen B27 (HLA-B27)+ gene OR     │ • Human leukocyte antigen B27 (HLA-B27)+ gene      │      95 │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Inflammatory back pain                             │ • Inflammatory back pain                           │      96 │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Inflammatory back pain                             │ • Inflammatory back pain                           │      96 │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Arthritis (physician-diagnosed)                    │ • Arthritis (physician-diagnosed)                  │      97 │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Dactylitis (physician-diagnosed)                   │ • Dactylitis (physician-diagnosed)                 │      97 │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Psoriasis (physician-diagnosed)                    │ • Psoriasis (physician-diagnosed)                  │      97 │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Arthritis (physician-diagnosed)                    │ • Arthritis (physician-diagnosed)                  │      97 │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Dactylitis (physician-diagnosed)                   │ • Dactylitis (physician-diagnosed)                 │      97 │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Psoriasis (physician-diagnosed)                    │ • Psoriasis (physician-diagnosed)                  │      97 │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Has chronic back pain of ≥3 months duration by     │ Has chronic back pain of =3 months duration by     │      98 │
│ history                                            │ history                                            │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ History of physician-diagnosed inflammatory bowel  │ • History of physician-diagnosed inflammatory      │      98 │
│ disease (IBD)                                      │ bowel disease (IBD)                                │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ History of uveitis confirmed by an ophthalmologist │ • History of uveitis confirmed by an               │      98 │
│                                                    │ ophthalmologist                                    │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Good response to nonsteroidal anti-inflammatory    │ • Good response to nonsteroidal anti-inflammatory  │      98 │
│ drugs (NSAID)                                      │ drugs (NSAID)                                      │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ History of physician-diagnosed inflammatory bowel  │ • History of physician-diagnosed inflammatory      │      98 │
│ disease (IBD)                                      │ bowel disease (IBD)                                │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ History of uveitis confirmed by an ophthalmologist │ • History of uveitis confirmed by an               │      98 │
│                                                    │ ophthalmologist                                    │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Good response to nonsteroidal anti-inflammatory    │ • Good response to nonsteroidal anti-inflammatory  │      98 │
│ drugs (NSAID)                                      │ drugs (NSAID)                                      │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Enthesitis (heel) physician-diagnosed (spontaneous │ • Enthesitis (heel) physician-diagnosed            │      99 │
│ pain or tenderness at examination of the site of   │ (spontaneous pain or tenderness at examination of  │         │
│ the insertion of the Achilles tendon or plantar    │ the site of the insertion of the Achilles tendon   │         │
│ fascia)                                            │ or plantar fascia)                                 │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Family history of SpA (presence of ankylosing      │ • Family history of SpA (presence of ankylosing    │      99 │
│ spondylitis, psoriasis, acute uveitis, reactive    │ spondylitis, psoriasis, acute uveitis, reactive    │         │
│ arthritis, or IBD)                                 │ arthritis, or IBD)                                 │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Enthesitis (heel) physician-diagnosed (spontaneous │ • Enthesitis (heel) physician-diagnosed            │      99 │
│ pain or tenderness at examination of the site of   │ (spontaneous pain or tenderness at examination of  │         │
│ the insertion of the Achilles tendon or plantar    │ the site of the insertion of the Achilles tendon   │         │
│ fascia)                                            │ or plantar fascia)                                 │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Family history of SpA (presence of ankylosing      │ • Family history of SpA (presence of ankylosing    │      99 │
│ spondylitis, psoriasis, acute uveitis, reactive    │ spondylitis, psoriasis, acute uveitis, reactive    │         │
│ arthritis, or IBD)                                 │ arthritis, or IBD)                                 │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Shows high disease activity at Screening and       │ Shows high disease activity at Screening and       │      99 │
│ Baseline of both a Total Back Pain score of ≥4 and │ Baseline of both a Total Back Pain score of =4 and │         │
│ a Bath Ankylosing Spondylitis Disease Activity     │ a Bath Ankylosing Spondylitis Disease Activity     │         │
│ Index (BASDAI) score of \>= 4                      │ Index (BASDAI) score of >= 4                       │         │
╘════════════════════════════════════════════════════╧════════════════════════════════════════════════════╧═════════╛

Only your personal trial has the following criteria:
╒════════════════════════════════════════════════════╤════════════════════════════════════════════════════╤═════════╕
│ Personal Criteria                                  │ CHIA Criteria                                      │   Score │
╞════════════════════════════════════════════════════╪════════════════════════════════════════════════════╪═════════╡
│ Must have minimum age of 18 Years                  │ Has physician-diagnosed active nr-axSpA with       │      38 │
│                                                    │ disease duration <= 5 years                        │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Meets one of the following criteria                │ Has a history of lymphoproliferative disease       │      41 │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Must have maximum age of 45 Years                  │ Has physician-diagnosed active nr-axSpA with       │      42 │
│                                                    │ disease duration <= 5 years                        │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Has active inflammation on magnetic resonance      │ Has any systemic inflammatory condition, including │      43 │
│ imaging (MRI) highly suggestive of sacroiliitis    │ psoriatic arthritis, active Lyme disease, systemic │         │
│ associated with spondyloarthropathy and 1 or more  │ lupus erythematosus, infectious arthritis,         │         │
│ of the following spondyloarthritis (SpA)           │ vasculitis, parvovirus infection, rheumatoid       │         │
│ characteristics                                    │ arthritis, active uveitis, or active IBD           │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Agrees to undergo screening for hepatitis B virus  │ Is known to be infected with human                 │      43 │
│ (HBV) and demonstrates negative results for        │ immunodeficiency virus (HIV) or seropositive for   │         │
│ hepatitis B surface antigen (HBsAg) and HBV        │ hepatitis C virus (HCV)                            │         │
│ deoxyribonucleic acid (DNA)                        │                                                    │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Elevated C-reactive protein (CRP)                  │ • Elevated CRP                                     │      51 │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Elevated C-reactive protein (CRP)                  │ • Elevated CRP                                     │      51 │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Has received any treatment listed below more       │ Has a history of latent or active granulomatous    │      54 │
│ recently than the indicated off-drug period prior  │ infection prior to Screening                       │         │
│ to Screening                                       │                                                    │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Has an Ankylosing Spondylitis Disease Activity     │ Has an ASDAS >= 2.1 at Screening                   │      57 │
│ Score (ASDAS) \>= 2.1 at Screening                 │                                                    │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Has physician-diagnosed active non-radiographic    │ Has physician-diagnosed active nr-axSpA with       │      77 │
│ axial spondyloarthritis (nr-axSpA) with disease    │ disease duration <= 5 years                        │         │
│ duration \<= 5 years                               │                                                    │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Has a HLA-B27+ gene and 2 or more of the following │ Has a HLA-B27+ gene and 2 or more of the SpA       │      84 │
│ SpA characteristics                                │ characteristics listed above                       │         │
╘════════════════════════════════════════════════════╧════════════════════════════════════════════════════╧═════════╛

Only CHIA has the following criteria:
╒════════════════════════════════════════════════════╤══════════════════════════════════════════════╤═════════╕
│ Personal Criteria                                  │ CHIA Criteria                                │   Score │
╞════════════════════════════════════════════════════╪══════════════════════════════════════════════╪═════════╡
│ Elevated C-reactive protein (CRP)                  │ • Elevated CRP                               │      51 │
├────────────────────────────────────────────────────┼──────────────────────────────────────────────┼─────────┤
│ Has an Ankylosing Spondylitis Disease Activity     │ Has an ASDAS >= 2.1 at Screening             │      57 │
│ Score (ASDAS) \>= 2.1 at Screening                 │                                              │         │
├────────────────────────────────────────────────────┼──────────────────────────────────────────────┼─────────┤
│ Has physician-diagnosed active non-radiographic    │ Has physician-diagnosed active nr-axSpA with │      77 │
│ axial spondyloarthritis (nr-axSpA) with disease    │ disease duration <= 5 years                  │         │
│ duration \<= 5 years                               │                                              │         │
├────────────────────────────────────────────────────┼──────────────────────────────────────────────┼─────────┤
│ Has a HLA-B27+ gene and 2 or more of the following │ Has a HLA-B27+ gene and 2 or more of the SpA │      84 │
│ SpA characteristics                                │ characteristics listed above                 │         │
╘════════════════════════════════════════════════════╧══════════════════════════════════════════════╧═════════╛

Levenshtein Ratio of Entire trial at once: 87
Average Levenshtein Ratio of individual lines: 89.03076923076924
OverAll Ratio: 88.01538461538462
